3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Conditions
Anxiety Disorders
2
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Hospice
1
Hematopoietic and Lymphatic System Neoplasm
1
Depression
1
Breast Neoplasms
1
Interventions
Psychotherapy
1
Psilocybin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Hospice
×
Psychotherapy
×
Clear all
NCT04950608
2026-02-17
PATH
Dana-Farber Cancer Institute
Phase 2
Completed
15 enrolled
26 charts